• Isoprinosine in Immunotherapy: Protocols, Benchmarks, and Pi

  2026-04-20

  Isoprinosine (inosine pranobex) stands out as a precision immunomodulator, enabling researchers to both amplify and fine-tune antiviral responses in cell-based and in vivo models. This article offers experimental blueprints, troubleshooting insights, and translational guidance—bridging novel herpesvirus biology with actionable workflow upgrades.

• EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Tracking Power

  2026-04-20

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) unlocks unmatched flexibility for real-time mRNA delivery tracking and robust gene expression analysis. Its dual fluorescence-bioluminescence design, immune-evasive 5-moUTP chemistry, and Cap1 capping deliver quantifiable, reproducible data in workflows where precision and traceability are mission-critical.

• Acifran: Selective HM74A/GPR109A Agonist for Lipid Research

  2026-04-19

  Acifran, or (R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid, is a validated HM74A/GPR109A and GPR109B agonist enabling targeted lipid metabolism studies. Recent structural biology confirms its specificity and mechanism, supporting its use as a hypolipidemic agent for research on lipid signaling pathway modulation.

• Cy5-UTP (Cyanine 5-UTP): Reliable RNA Labeling for FISH & Ar

  2026-04-18

  This article addresses common laboratory challenges in RNA labeling workflows and demonstrates how Cy5-UTP (Cyanine 5-UTP), SKU B8333, delivers consistent, high-sensitivity results. Drawing on peer-reviewed evidence and real-world scenarios, it compares Cy5-UTP’s performance, reproducibility, and vendor reliability, empowering scientists to optimize fluorescence-based assays with confidence.

• GSK-923295: Precision CENP-E Inhibition for Mitotic Assays

  2026-04-17

  GSK-923295 stands out as a highly potent CENP-E inhibitor, enabling researchers to probe chromosome alignment and mitotic arrest with exceptional specificity. This guide synthesizes recent advances in centromere biology and offers protocol-driven strategies and troubleshooting insights to maximize reproducibility in cancer research workflows.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Mechanistic

  2026-04-16

  Wang et al. (2018) systematically dissected the entry mechanism of genotype III grass carp reovirus (GCRV104), revealing a strict dependency on clathrin-mediated endocytosis and endosomal acidification. Their pharmacological inhibitor analysis, including the use of latrunculin B, clarified that actin polymerization is non-essential for viral internalization—informing both virology research and the design of cytoskeletal interrogation assays.

• Cediranib (AZD2171): Optimizing In Vitro Angiogenesis Assays

  2026-04-15

  Cediranib (AZD2171) stands out for its sub-nanomolar VEGFR inhibition, making it the benchmark tool for dissecting angiogenesis and tumor growth in cancer research. This article delivers protocol-ready guidance, troubleshooting strategies, and workflow enhancements, bridging reference literature with actionable lab practice.

• Dual-Action Inhibition of p38α MAPK: Dephosphorylation Mecha

  2026-04-14

  The reference study uncovers how certain kinase inhibitors, including those structurally related to RWJ 67657 (JNJ-3026582), can both block p38α MAP kinase activity and accelerate its dephosphorylation by altering activation loop conformation. These findings shed light on new strategies for achieving greater specificity and potency in targeting inflammatory signaling pathways, with implications for improving tools used in cytokine regulation research.

• rhBNP Prevents Renal IR Injury by Inhibiting Ferroptosis via

  2026-04-13

  This study demonstrates that recombinant human brain natriuretic peptide (rhBNP) protects against renal ischemia-reperfusion (IR) injury by inhibiting ferroptosis, primarily through upregulation of selenocysteine lyase (SCLY) and enhanced selenium recycling. The findings reveal a new mechanistic target for acute kidney injury (AKI) intervention and provide a platform for further investigation of selenium-dependent antioxidant pathways.

• DOT1L Inhibition with EPZ5676 Attenuates Renal Fibrosis

  2026-04-12

  This study demonstrates that targeting DOT1L with the selective inhibitor EPZ5676 suppresses renal fibroblast activation and epithelial-mesenchymal transition, thereby attenuating renal fibrosis in a murine model. The findings highlight DOT1L-mediated H3K79 methylation as a key epigenetic driver in progressive kidney disease, expanding the utility of DOT1L inhibitors beyond oncology.

• Procainamide Hydrochloride in Liposomal Delivery: A New Fron

  2026-04-12

  Discover the multifaceted roles of Procainamide Hydrochloride as a cardiac sodium channel blocker and DNMT1 inhibitor, with a special focus on its innovative use in liposomal delivery systems for enhanced assay performance. This article provides advanced insights and practical guidance for researchers exploring next-generation applications.

• Protease Inhibitor Cocktail: Optimizing Protein Extraction W

  2026-04-11

  Unlock high-integrity protein data with the Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO). This solution delivers robust protection across phosphorylation-sensitive workflows and advanced genotoxicity assays, outperforming conventional inhibitors in both flexibility and reproducibility.

• Aconitase Activity Colorimetric Assay Kit: Rapid Oxidative D

  2026-04-11

  Harness the Aconitase Activity Colorimetric Assay Kit for sensitive, high-throughput detection of mitochondrial aconitase activity and robust quantification of oxidative damage. This versatile platform streamlines workflows in immunometabolic and stress response research, setting a new standard for TCA cycle enzyme assays.

• A40926: Glycopeptide Antibiotic Innovations for MRSA and ...

  2026-04-10

  A40926 redefines glycopeptide antibiotic workflows with unmatched potency against Gram-positive and Neisseria gonorrhoeae pathogens. Its unique mechanism and robust fermentation yields make it a critical tool for advanced cell wall biosynthesis and antibiotic resistance studies. Discover how to leverage A40926 for superior in vitro assays, animal models, and next-generation antibiotic development.

• A40926: Glycopeptide Innovation for Antibiotic Resistance...

  2026-04-09

  Explore the multifaceted role of A40926 as a natural glycopeptide antibiotic and dalbavancin precursor in advanced bacterial cell wall synthesis inhibition and antibiotic resistance studies. This article uniquely examines A40926’s biosynthetic regulation, comparative efficacy, and translational potential in multidrug-resistant pathogen research.

407 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page